Patent Assignment
Reel/Frame 023137/0716
Assignment of Assignor's Interest
Recorded: 2009-08-24
Pages: 11
Assignor
MYRIAD GENETICS, INC.
Executed: 2009-06-30
Assignee
MYRIAD PHARMACEUTICALS, INC.
320 WAKARA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property
(1)
Methods of Preparing Dosage Compositions Containing Substituted (4-Phenyl)-Methyl-(Quinazolin-4-Yl)-Amine Compounds
Application:
11/692,655 →
Publication:
US 2007/0249632
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0911 →
Security Agreement
Feb 19, 2014
From: IMMUNE PHARMACEUTICALS INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 032277/0353 →
Release of Security Interest
Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036255/0778 →